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Original Investigations

Ventilation Heterogeneity in
Ex-smokers without
Airflow Limitation
Damien Pike, BSc1, Miranda Kirby, PhD2, Fumin Guo, MEng1, David G. McCormack, MD, FRCPC3,
Grace Parraga, PhD1
Rationale and Objectives: Hyperpolarized 3He magnetic resonance imaging (MRI) ventilation abnormalities are visible in ex-smokers
without airflow limitation, but the clinical relevance of this is not well-understood. Our objective was to phenotype healthy ex-smokers
with normal and abnormally elevated ventilation defect percent (VDP).
Materials and Methods: Sixty ex-smokers without airflow limitation provided written informed consent to 3He MRI, computed tomography (CT), and pulmonary function tests in a single visit. 3He MRI VDP and apparent diffusion coefficients (ADCs) were measured for wholelung and each lung lobe as were CT measurements of emphysema (relative area [RA] with attenuation #950 HU, RA950) and airway
morphology (wall area percent [WA%], lumen area [LA] and LA normalized to body surface area [LA/BSA]).
Results: In 42 ex-smokers, there was abnormally elevated VDP and no significant differences for pulmonary function, RA950, or airway
measurements compared to 18 ex-smokers with normal VDP. Ex-smokers with abnormally elevated VDP reported significantly greater
3
He ADC in the apical lung (right upper lobe [RUL], P = .02; right middle lobe [RML], P = .04; and left upper lobe [LUL], P = .009). Whole
lung (r = 0.40, P = .001) and lobar VDP (RUL, r = 0.32, P = .01; RML, r = 0.46, P = .002; right lower lobe [RLL], r = 0.38, P = .003; LUL, r = 0.35,
P = .006; and left lower lobe, r = 0.37, P = .004) correlated with regional 3He ADC. Although whole-lung VDP and CT airway morphology
measurements were not correlated, regional VDP was correlated with RUL LA (r = 0.37, P = .004), LA/BSA (r = 0.42, P = .0008), RLL WA
% (r = 0.28, P = .03), LA (r = 0.28, P = .03), and LA/BSA (r = 0.37, P = .004).
Conclusions: Abnormally elevated VDP in ex-smokers without airflow limitation was coincident with very mild emphysema detected using
MRI and regional airway remodeling detected using CT representing a subclinical obstructive lung disease phenotype.
Key Words: Hyperpolarized 3He magnetic resonance imaging; computed tomography; airways disease; emphysema.
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C

hronic obstructive pulmonary disease (COPD) is
characterized by irreversible airflow limitation
caused by small airway remodeling, airway obliteration (1), and emphysematous tissue destruction (2). COPD
is typically diagnosed after respiratory symptoms become
obvious and intolerable (3), and this usually occurs when
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spirometry measurements of lung function reflect airflow limitation and obstruction. However, it is well understood that
ex- and current-smokers may report normal lung function
(3) and mild symptoms, and this may represent an early or
‘‘subclinical’’ phase. A deep understanding of the underlying
morphologic changes that accompany this ‘‘subclinical’’ phase
is lacking, mainly because methods for evaluating pulmonary
function cannot detect very mild or early structure–function
abnormalities.
Hyperpolarized 3He magnetic resonance imaging (MRI)
ventilation heterogeneity has been shown in patients with pulmonary diseases such as COPD (4,5), asthma (6,7), and cystic
fibrosis (8). At the same time, however, preclinical or subclinical 3He ventilation heterogeneity has also been observed in
volunteers without clinical signs or symptoms of lung disease
such as healthy elderly never-smokers (9), ex-smokers without
airflow limitation (10), in second-hand smoke exposed adults
(11), and current-smokers without disease (12). To evaluate
the underlying anatomic and structural determinants of ventilation heterogeneity, thoracic x-ray computed tomography
(CT) has been used to help determine the spatial relationship
of airways disease and emphysema with ventilation
1
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abnormalities. For example, recent work (13) provided evidence that in COPD, 3He ventilation defects represent regions
of emphysema and airways disease and that this relationship
depends on disease severity. In asthma (7), 3He ventilation
heterogeneity was also shown to be spatially related to abnormally remodeled airways. However, the pathophysiological
origins and contributions of very mild or subclinical airways
disease and emphysema to ventilation heterogeneity in exsmokers without airflow limitation have not been investigated
and remain poorly understood.
To better understand the pathophysiological features of
ventilation heterogeneity in the ‘‘subclinical phase’’ of
obstructive lung disease in otherwise normal healthy exsmokers, we evaluated a group of well-characterized exsmokers without airflow limitation using both MRI and
CT. Because of previous research that has suggested that
microstructural alveolar remodeling and small airway obliteration occur in subclinical and mild COPD (1,2,11,12), we
hypothesized that in normal ex-smokers, 3He ventilation abnormalities would be spatially and quantitatively related to a
combination of very mild airways disease and emphysema.
MATERIALS AND METHODS
Study Participants

Study participants provided written informed consent to a
protocol approved by a local research ethics board and Health
Canada, and the protocol was compliant with the Personal Information Protection and Electronic Documents Act (Canada) and Health Insurance Portability and Accountability
Act (USA). Research volunteers were recruited from a
tertiary health care practice. Each visit was completed in
approximately 2 hours when spirometry, plethysmography,
the six-minute walk test, St. George’s Respiratory Questionnaire, 3He MRI, and CT were completed.
Spirometry and Plethysmography

Spirometry was performed according to the American
Thoracic Society guidelines (14). Whole-body plethysmography was used to measure lung volumes (MedGraphics Corporation, St. Paul, MN), and the attached gas analyzer was
used to measure diffusing capacity of the lung for carbon
monoxide.
Imaging

MRI was performed on a 3T Discovery MR750 (General
Electric Health Care, Milwaukee, WI) system with subjects
in inspiratory breath hold at functional residual capacity
(FRC) + 1 L. 1H MRI was acquired before 3He MRI after
inhalation of 1 L high purity, medical grade nitrogen (N2)
from FRC using the whole-body radiofrequency coil and a
fast spoiled gradient-recalled-echo sequence (FGRE; total
scan time  12 s, repetition time [TR] = 4.3 ms, echo
2
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time [TE] = 1.0 ms, flip angle = 30 , partial echo
percent = 62.5%, bandwidth [BW] = 62.5 kHz, field of
view [FOV] = 40  40 cm, matrix size = 128  80 [zero
padded to 128  128], number of excitations [NEXs] = 1,
slice thickness = 15 mm, number of slices  14 [depending
on subject size], 0 gap). 3He MRI was acquired using a rigid
elliptical transmit–receive chest coil (RAPID, Biomedical,
Rimpar, Wuerzburg, Germany) with subjects in inspiratory
breath-hold after inhalation from FRC of a 1 L mixture of
hyperpolarized 3He (5 mL/kg body weight) diluted with
N2. 3He static-ventilation images were acquired using a
partial-echo FGRE sequence (total scan time  10 s,
TR = 3.8 ms, TE = 1.0 ms, flip angle = 7 , partial echo
percent = 62.5%, BW = 62.5 kHz, FOV = 40  40 cm, matrix size = 128  80 [zero padded to 128  128], NEX = 1,
slice thickness = 15 mm, number of slices  14 (depending
on subject size), 0 gap). 3He diffusion-weighted MR imaging was completed using a centric k-space sampled FGRE
sequence (total scan time  14 s, TR = 6.8 ms,
TE = 4.5 ms, flip angle = 8 , partial echo percent = 62.5%,
BW = 62.5 kHz, FOV = 40
 40 cm, matrix
size = 128  80 [zero padded to 128  128], NEX = 1, slice
thickness = 30 mm, number of slices  7, 0 gap) that acquired two interleaved slices with and without diffusion
sensitization (b = 1.6 s/cm2, maximum gradient amplitude
(G) = 1.94 G/cm, rise/fall time = 0.5 ms, gradient
duration = 0.46 ms, and diffusion time = 1.46 ms).
CTwas acquired within 30 minutes of MRI using a 64 slice
Lightspeed VCT system (General Electric Health Care). Subjects were transported to the CT suite by wheelchair to prevent the potential for exercise-induced changes between
MRI and CT image acquisitions. CT was acquired during
inspiratory breath-hold of FRC+1 L of N2 using a single spiral
acquisition from apex to base with subjects in the supine position (detector configuration = 64  0.625 mm, tube
voltage = 120 kVp, tube current = 100 mAs, tube rotation
time = 500 ms, and pitch = 1). The total effective dose was
1.8 mSv as calculated using manufacturer settings and the
ImPACT CT dosimetry calculator based on Health Protection Agency (UK) NRPB-SR250.
Image Analysis

Ventilation heterogeneity or regions of ‘‘signal void’’ were
quantified as 3He ventilation defect percent (VDP) using
semiautomated software generated in MATLAB (Mathworks,
Natick, MA) as previously described (15). Lobar VDP was
generated by registering the segmented thoracic CT lobe
mask from VIDA Pulmonary Workstation 2.0 (VIDA Diagnostics Inc., Coralville, IA) to 3He MRI ventilation images
using deformable registration, and generating VDP for each
lobe (right upper lobe [RUL], right middle lobe [RML], right
lower lobe [RLL], left upper lobe [LUL], left lower lobe
[LLL]) using hierarchical k-means clustering (15).
All ex-smokers were classified as having normal or abnormally elevated VDP using a threshold based on the upper limit
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TABLE 1. Demographic, Pulmonary Function, and Imaging Data
Parameter (SD)

All n = 60

Normal VDP (n = 18)

Elevated VDP (n = 42)

P Value*

Age, y
Male, n (%)
Pack years
Years quit smoking
BMI, kg/m2
FVC, %pred
FEV1, %pred
FEV1/FVC
RV/TLC, %pred
DLCO, %pred
6MWD, m
SGRQ total
WA %
LA, mm2
LA/BSA, mm2/m2
Airway count
RA950, %
VDP, %
ADC, cm2/s

69 (9)
38 (63)
28 (16)
19 (15)
29 (4)
97 (13)
104 (13)
80 (6)
103 (15)
80 (20)
404 (95)
36 (26)
65 (2)
14 (3)
7 (2)
115 (37)
1.2 (1.0)
6 (3)
0.28 (0.04)

67 (10)
9 (50)
27 (14)
13 (12)
29 (5)
100 (10)
106 (12)
80 (6)
104 (12)
87 (16)
433 (81)
22 (20)
65 (2)
13 (2)
7 (1)
106 (28)
0.8 (0.5)
3 (1)
0.26 (0.03)

70 (9)
29 (69)
28 (17)
21 (15)
30 (4)
95 (14)
102 (14)
80 (6)
103 (16)
77 (22)
392 (98)
23 (22)
65 (2)
14 (4)
7 (2)
119 (40)
1.4 (1.1)
7 (3)
0.29 (0.03)

.23 (1.0)
.17 (1.0)
.86 (1.0)
.06 (1.0)
.5 (1.0)
.18 (1.0)
.28 (1.0)
.78 (1.0)
.76 (1.0)
.11 (1.0)
.12 (1.0)
.78 (1.0)
.89 (0.89)
.36 (1.0)
.81 (1.0)
.20 (1.0)
.08 (1.0)
<.0001 (<.0001)
.01 (.18)

ADC, apparent diffusion coefficient; BMI, body mass index; BSA, body surface area; DLCO, diffusing capacity for carbon monoxide; FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity; LA, mean fifth generation airway lumen area; 6MWD, six-minute walk distance;
RA950, relative area of the lung parenchyma with attenuation #950 HU; RV, residual volume; SD, standard deviation; SGRQ, St. Georges Respiratory Questionnaire; TLC, total lung capacity; VDP, ventilation defect percent; WA%, mean fifth generation airway wall area percent.
*Holm–Bonferroni corrected P Values in parentheses, P Value considered significant when P < .05.

of normal (95% confidence interval [CI]) of VDP in 51
healthy elderly never-smokers (9) which was calculated using
the following equation:
s
95% CL ¼ x þ 1:96· pﬃﬃﬃ
n
where x is the mean VDP of the 51 healthy never-smokers, s
is the standard deviation of VDP of the 51 healthy neversmokers, and n is the total number of healthy neversmokers. The upper limit of normal (95% CI) for VDP was
calculated to be 4.3%. Therefore, ex-smokers with VDP
<4.3% were classified as normal, whereas ex-smokers with
VDP $4.3% were classified as having abnormally elevated
VDP.
3
He MRI apparent diffusion coefficients (ADCs) were
generated as previously described (16).
CT volumes were evaluated using Pulmonary Workstation
2.0 to generate airway wall area percent (WA%), lumen area
(LA), and airway count. It was previously shown that airway
LA is related to body surface area (BSA) (17,18), and
therefore, LA was normalized to BSA (LA/BSA). CT WA
%, LA, and LA/BSA were measured for subsegmental
bronchi including RB1, RB5, RB8, LB1, and LB8 airways
because each of these feed individual lobes (RB1-RUL,
RB5-RML, RB8-RLL, LB1-LUL, and LB8-LLL), and
they were measurable for each subject. Emphysema was also
measured using Pulmonary Workstation 2.0 including the
relative area of the lung with attenuation #950 Hounsfield

units (HU) (RA950) for whole-lung and each individual lung
lobe.
Statistics

All statistical tests were performed in IBM SPSS V22 (SPSS
Inc., Chicago, IL). Normality of data was tested using the Shapiro–Wilk test. A one-way analysis of variance was used to
compare multiple parameters, and univariate comparisons
were investigated using unpaired two-tailed t tests for
normally distributed data and Mann–Whitney U tests for
non-normally distributed data. Spearman correlations were
performed for non-normally distributed data.
RESULTS
A summary of demographic, pulmonary function test, and
imaging measurements is provided in Table 1 for all 60
subjects, whereas Supplemental Table 1 (online) provides a
subject listing of data. All participants reported normal
spirometry measurements (forced expiratory volume in 1 second [FEV1] = 104  13%, FEV1/forced vital capacity
[FVC] = 80  6%) and no subjects reported Global initiative
for Chronic Obstructive Lung Disease unclassified COPD
(19). Eighteen subjects (18 of 60 = 30%) reported normal
VDP and 42 (42 of 60 = 70%) subjects reported abnormally
elevated VDP. As shown in Figure 1 for three representative
subjects, volunteers with normal VDP showed small or no
ventilation defects along the periphery of the lung, whereas
3
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Figure 1. 3He magnetic resonance imaging ventilation and computed tomography airway trees in representative ex-smokers with normal (S1–
S3) and abnormally elevated ventilation defect percent (VDP) (S4–S6) (airway measurements displayed as wall area percent and lumen area
[mm2]) S1 = 70-year-old woman, 12 pack years, forced expiratory volume in 1 second (FEV1) = 93% and VDP = 2%; S2 = 59-year-old woman,
18 pack years, FEV1 = 97% and VDP = 2%; S3 = 51–year-old woman, 20 pack years, FEV1 = 103% and VDP = 4%; S4 = 74–year-old man, 50
pack years, FEV1 = 89% and VDP = 8%; S5 = 79–year-old man, 10 pack years, FEV1 = 88% and VDP = 11%; and S6 = 74–year-old man, 60
pack years, FEV1 = 95% and VDP = 6%.

participants with abnormally elevated VDP showed evidence
of patchy ventilation throughout the lung and on the periphery. The qualitative spatial relationship for patchy ventilation
and subsegmental airway morphology reconstructed from
CT is also shown in Figure 1.
As shown in Table 1, subjects with abnormally elevated
VDP were not significantly different (P > .05) with respect
to pulmonary function test or CT measurements, but they
did report significantly greater (P = .01) 3He ADC than subjects with normal VDP.
Table 2 shows quantitative airway morphology and emphysema measurements for subjects with normal and abnormally
elevated VDP. No significant differences were observed for
whole-lung airway (mean of fifth generation airways) WA%
(P = .88), LA (P = .50), or LA/BSA (P = .57), and this was
consistent in all lung lobes. Table 2 and Figure 2 show that

4

only 3He MRI ADC was significantly greater in the apical
lung (RUL, P = .02; RML, P = .04; and LUL, P = .009) in
subjects with elevated VDP.
Table 3 shows the relationships for VDP with airway
morphology and emphysema measurements. Whole lung
VDP was significantly correlated with whole lung ADC
(r = 0.40, P = .001) and whole lung RA950 (r = 0.34,
P = .008). As shown in Table 3 and in more detail in
Figure 3, regional VDP correlated with regional ADC in
each of the lung lobes (RUL: r = 0.32, P = .01; RML:
r = 0.46, P = .002; RLL: r = 0.38, P = .003; LUL:
r = 0.35, P = .006; and LLL: r = 0.37, P = .004). As shown
in Table 3, whole lung VDP did not correlate with whole
lung (mean of fifth generation airways) WA%, LA, or LA/
BSA. There were no significant correlations for regional
VDP and airway morphologic measurements in the RML
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TABLE 2. Whole Lung and Regional Measurements for Ex-smokers with Normal and Elevated VDP
Parameter (SD)
Whole lung
WA%*
LA, mm2*
LA/BSA, mm2/m2*
VDP, %
ADC, cm2/s
RA950, %
Right upper lobe
RB1 WA%
RB1 LA, mm2
RB1 LA/BSA, mm2/m2
VDP, %
ADC, cm2/s
RA950, %
Right middle lobe
RB5 WA%
RB5 LA, mm2
RB5 LA/BSA, mm2/m2
VDP, %
ADC, cm2/s
RA950, %
Right lower lobe
RB8 WA%
RB8 LA, mm2
RB8 LA/BSA, mm2/m2
VDP, %
ADC, cm2/s
RA950, %
Left upper lobe
LB1 WA%
LB1 LA, mm2
LB1 LA/BSA, mm2/m2
VDP, %
ADC, cm2/s
RA950, %
Left lower lobe
LB8 WA%
LB8 LA, mm2
LB8 LA/BSA, mm2/m2
VDP, %
ADC, cm2/s
RA950, %

Normal VDP (n = 18)

Elevated VDP (n = 42)

P Value

65 (2)
13 (2)
7 (1)
3 (1)
0.26 (0.03)
0.8 (0.5)

65 (2)
14 (4)
7 (2)
7 (3)
0.29 (0.03)
1.4 (1.1)

.88
.50
.57
<.0001
.01
.08

62 (2)
25 (5)
13 (3)
3 (2)
0.24 (0.03)
0.7 (0.6)

61 (4)
25 (11)
13 (6)
5 (4)
0.27 (0.03)
1.2 (1.2)

.29
.64
.39
.02
.02
.08

63 (4)
22 (13)
12 (7)
6 (9)
0.24 (0.03)
1.6 (1.0)

62 (4)
21 (8)
11 (4)
9 (10)
0.27 (0.04)
2.0 (1.8)

.25
.80
.99
.04
.04
.79

62 (3)
21 (8)
11 (5)
5 (3)
0.25 (0.03)
0.6 (0.4)

62 (3)
21 (7)
11 (4)
8 (6)
0.27 (0.03)
1.0 (1.0)

.43
.99
.67
.02
.07
.42

63 (3)
15 (4)
8 (2)
4 (4)
0.25 (0.03)
1.0 (0.6)

63 (3)
18 (6)
9 (3)
8 (8)
0.28 (0.04)
1.8 (1.7)

.52
.19
.34
.02
.009
.22

59 (4)
30 (11)
17 (8)
3 (1)
0.25 (0.03)
0.7 (0.4)

60 (4)
28 (12)
14 (6)
7 (3)
0.27 (0.04)
1.1 (1.1)

.68
.27
.13
<.0001
.07
.42

ADC, 3He magnetic resonance imaging apparent diffusion coefficient; BSA, body surface area; LA, lumen area; LB1, left upper lobe apical
bronchus; LB8, left lower lobe subsegmental bronchus; RA950, relative area of the lung parenchyma with attenuation #950 HU; RB1, right
upper lobe apical bronchus; RB5, right middle lobe lateral bronchus; RB8, right lower lobe subsegmental bronchus; SD, standard deviation;
VDP, 3He magnetic resonance imaging ventilation defect percent; WA%, wall area percent.
*Mean of fifth generation airways.

(RB5 morphology), LUL (LB1 morphology), or LLL (LB8
morphology). However, as shown Figure 4 in more detail,
RUL VDP significantly correlated RB1 morphologic measurements (LA: r = 0.37, P = .004 and LA/BSA:
r = 0.42, P = .0008) and RLL VDP significantly correlated
with RB8 morphologic measurements (WA%: r = 0.28,
P = .03; LA: r = 0.28, P = .03; and LA/BSA: r = 0.37,
P = .004).

DISCUSSION
We acquired 3He MRI and CT in 60 ex-smokers without
airflow limitation and made the following observations: 1)
42 of 60 volunteers reported abnormally elevated 3He VDP,
and these subjects reported normal airflow and lung volume
measurements that were not significantly different from 18
ex-smokers with normal VDP, 2) there was significantly
5
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Figure 2. Whole lung (WL) and
regional emphysema measurements in ex-smokers with normal
(n = 18) and abnormally elevated
ventilation defect percent (VDP;
n = 42; Holm–Bonferroni corrected
P Values in parentheses). ADC was
significantly greater in apical lung
in subjects with elevated VDP. After
correcting for multiple comparisons,
only the comparison of LUL ADC remained on the threshold of significance. (a) Whole lung ADC
(P = .02, corrected 0.08), (b) right
upper lobe ADC (P = .02, corrected
0.1), (c) left upper lobe ADC
(P = .009, corrected 0.05), (d) right
middle lobe ADC (P = .04, corrected
0.12), (e) left lower lobe ADC
(P = .07, corrected 0.07), and (f) right
lower lobe ADC (P = .07, corrected
0.10). ADC, apparent diffusion coefficient; LLL, left lower lobe; LUL, left
upper lobe; RLL, right lower lobe;
RML, right middle lobe; RUL, right
upper lobe.

greater (worse) apical lung 3He ADC in the 42 ex-smokers
with abnormally elevated VDP as compared to ex-smokers
with normal VDP, but there were no other imaging differences between the subgroups, 3) 3He VDP was significantly
correlated with whole lung and regional ADC, and 4) whole
lung 3He VDP was not correlated with whole lung airway
morphologic measurements, although RUL and RLL VDP
was associated with thicker airway walls (WA%) and narrowed
airway lumen (LA) in those regions of interest.
6

We observed that 42 ex-smokers reported VDP $95% CI
for VDP in never-smokers (9). Although all participants had
a significant smoking history (mean pack years = 28),
spirometry and CT measurements showed no evidence of
lung function decline or lung destruction (FEV1/
FVC = 80  6%, mean FEV1%pred = 104  13%, mean
RA950 = 1.2  1.0%). The cutoffs for diagnosing airflow
obstruction using spirometry are well established as FEV1/
FVC <70% and/or (unclassified) FEV1%pred <80% (3), and
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TABLE 3. Relationship of 3He MRI VDP with Airways Disease
and Emphysema Measurements
Parameter
Whole lung VDP
WA%*
LA*
LA/BSA*
ADC
RA950
Right upper lobe VDP
RB1 WA%
RB1 LA
RB1 LA/BSA
ADC
RA950
Right middle lobe VDP
RB5 WA%
RB5 LA
RB5 LA/BSA
ADC
RA950
Right lower lobe VDP
RB8 WA%
RB8 LA
RB8 LA/BSA
ADC
RA950
Left upper lobe VDP
LB1 WA%
LB1 LA
LB1 LA/BSA
ADC
RA950
Left lower lobe VDP
LB8 WA%
LB8 LA
LB8 LA/BSA
ADC
RA950

Spearman r

P Value

0.002
0.04
0.04
0.40
0.34

.99
.76
.75
.001
.008

0.24
0.37
0.42
0.32
0.15

.06
.004
.0008
.01
.27

0.11
0.003
0.02
0.46
0.24

.40
.98
.91
.002
.07

0.28
0.28
0.37
0.38
0.21

.03
.03
.004
.003
.11

0.07
0.13
0.01
0.35
0.23

.62
.33
.94
.006
.08

0.04
0.05
0.02
0.37
0.26

.73
.68
.86
.004
.05

ADC, 3He MRI apparent diffusion coefficient; BSA, body surface
area; LA, lumen area; LB1, left upper lobe apical bronchus; LB8,
left lower lobe subsegmental bronchus; MRI, magnetic resonance
imaging; RA950, relative area of the lung parenchyma with
attenuation #950 HU; RB1, right upper lobe apical bronchus;
RB5, right middle lobe lateral bronchus; RB8, right lower lobe subsegmental bronchus; VDP, 3He MRI ventilation defect percent; WA
%, wall area percent.
*Mean of fifth generation airways.

various thresholds ranging from RA950 = 7%–10% have been
used to identify emphysema predominant phenotypes (20),
and we noted that the spirometry and CT measurements
from the ex-smokers in our study did not cross any of these
thresholds. At the same time, we were surprised that these
same measurements showed no significant differences between subjects with elevated VDP compared to subjects
with normal VDP. Previous work (10) in ‘‘healthy’’ smokers
showed significantly different MRI ventilation measure-

ments as compared to never-smokers and COPD smokers
and our findings build on this previous work by showing
that ex-smokers with abnormally elevated VDP also showed
significantly greater whole-lung and apical lung 3He ADC.
In this regard, it is important to note that 3He ADC provides
a surrogate measure of microstructural emphysema (21) and
was previously shown to be sensitive to very mild emphysematous changes by detecting differences in subjects exposed
only to second-hand smoke (11). We observed that subjects
with elevated VDP reported greater whole-lung and apical
lung 3He ADC. Previous work (22) evaluated the anatomic
ADC distribution in more severe COPD and established
the presence of elevated ADC in the apical lung regions,
and this is in agreement with predominant centrilobular
emphysema in such patients. However, to our knowledge,
the spatial distribution of ADC in ex-smokers without
COPD has not yet been evaluated. We did not observe differences in CT emphysema (RA950) measurements. However, previous research (23) showed that CT-derived
emphysema measurements may underestimate the extent of
emphysema in very mild disease. The mean RA950 in the
ex-smokers in our study was very low (mean
RA950 = 1.2%), and this may reflect why CT RA950 was
not significantly different between subgroups. Nevertheless,
these results suggest that ex-smokers with a significant smoking history and abnormal 3He VDP but without airflow limitation may also have a mild or subclinical form of
centrilobular emphysema that is not detected using CT or
conventional pulmonary function tests.
Whole lung and regional VDP were correlated with ADC
which suggests that ventilation abnormalities and very mildly
abnormal parenchyma coexisted in these otherwise normal
ex-smokers. We evaluated regional (lobar) correlations for
3
He VDP and ADC because a direct spatial comparison previously described in COPD patients (13) was not feasible here.
This previous approach (13) evaluated the direct spatial relationship between 3He ventilation defects and emphysema by
evaluating the overlap of RA950 (emphysema) regions and
3
He ventilation defects. As compared to COPD patients
with severe emphysema (RA950>15%), the ex-smokers here
reported very low or normal RA950 and therefore the spatial
overlap of 3He ventilation defects and RA950 could not be
evaluated. We wonder about the long-term consequences of
these very mild abnormalities in ventilation and emphysema
measurements and whether these are predictors of a transition
to COPD. Future longitudinal evaluations in these subjects
are warranted and will be undertaken.
It was not expected that whole-lung airway measurements
would show differences between subgroups because it is
widely appreciated that obstructive disease is regionally (and
not uniformly) distributed in the lung (24). However, it was
surprising that we did not detect or measure abnormal or
different regional airway morphologies in the ex-smokers
with abnormally elevated VDP, especially because wholelung and lobar VDP was significantly greater in these participants. We think one explanation for this may be related to
7
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Figure 3. Relationships for whole lung and regional ventilation defect percent (VDP) with 3He magnetic resonance imaging emphysema measurements. (a) Whole lung (WL) VDP correlated with WL ADC (r = 0.40, P = .001), (b) RUL VDP correlated with RUL ADC (r = 0.32, P = .01), (c) RLL
VDP correlated with RLL ADC (r = 0.38, P = .003), (d) RML VDP correlated with RML ADC (r = 0.46, P = .002), (e) LUL VDP correlated with LUL
ADC (r = 0.35, P = .006), and (f) LLL VDP correlated with LLL ADC (r = 0.37, P = .004). ADC, apparent diffusion coefficient; LLL, left lower lobe;
LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe.

the airways we measured and the fact that they may not have
been distal enough to reflect such mild disease. We observed
significant correlations between airway morphology and
VDP in the RUL and RLL. Previous studies (25,26) have
shown that RUL and RLL airway morphology is
significantly correlated with whole-lung function (assessed
by spirometry) in COPD, but these studies did not investigate
regional relationships with function. The observation that
thickened airway walls and narrowed airway lumens correlate
with increasing ventilation heterogeneity in the RUL, and
RLL suggests that there may be a structure–function relationship between airway morphology and ventilation in exsmokers. However, we must caution that this was not
observed for the left lung lobes. At the same time, we note
that left lung airway morphology and its relationship to
regional and global lung function has largely been underinvestigated compared to right lung airway morphology, perhaps
because the relative sizes of the major airways, make right
lung investigations more easily undertaken. These findings
may also be highlighting some of the limitations of CTand ad8

vantages of MRI for pulmonary imaging and characterization
of very mild lung disease. As described elsewhere (27,28), CT
measurements are limited because of the inherent spatial
resolution limit achievable on thoracic CT scans. On the
other hand, MRI ADC provides a way to reveal subtle
parenchymal changes to the alveolar microstructure, and the
subjects in our study certainly exemplify a patient group in
whom MRI is highly advantageous.
Previous work with micro-CT has established that small
airway obliteration and not macroscopic emphysema may be
the dominant contributor to airflow obstruction in the early
and mild COPD grades (1,2). At the same time, 3He MRI
studies have provided evidence that mild microstructural
alveolar remodeling occurs in current-smokers without
COPD (12,29) and individuals with no (30) or very mild
exposure to cigarette smoke (11). Although it is not known
definitively how mild alveolar abnormalities influence airflow,
taken together, these previous findings suggest that small airways disease and mild emphysema are both present in elderly
never-, ex-, or current-smokers without COPD. In the
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Figure 4. Relationships for regional ventilation defect percent (VDP) with computed tomography airways disease measurements. Right upper
lobe (RUL) VDP correlated with (a) RB1 lumen area (LA) (r = 0.37, P = .004), (b) RB1 LA/body surface area (BSA) (r = 0.42, P = .0008) but not
(c) RB1 wall area percent (WA%) (r = 0.24, P = .06). Right lower lobe (RLL) VDP correlated with (d) RB8 LA (r = 0.28, P = .03), (e) RB8 LA/BSA
(r = 0.37, P = .004), and (f) RB8 WA% (r = 0.28, P = .03).

present study, we observed spatial and quantitative relationships for ventilation defects with subsegmental CT airway
morphologic abnormalities and 3He ADC. This is in agreement with the hypothesis that ventilation abnormalities and
mild emphysema coexist in normal ex-smokers.
We must acknowledge several limitations. We measured
five individual subsegmental airways (RB1, RB5, RB8,
LB1, and LB8) and not all subsegmental airways. We chose
to evaluate these five airways because they were most easily
visible and measurable on thoracic CT and directly lead to
the individual lung lobes of interest. Although it would be
possible to quantitatively evaluate more distal subsegmental
airways, the reproducibility of these measurements in all subjects would be difficult to determine. After correcting for familywise error, the comparisons between whole-lung and
regional ADC between groups did not remain statistically significant. Although these corrected comparisons did not reach
statistical significance, the trend toward elevated VDP and
ADC suggests a subclinical centrilobular emphysema phenotype. Although we think the results of our analysis point to
very mild emphysema and airways disease in ex-smokers
without airflow limitation, we also believe that these findings

should be investigated further in a larger ex-smoker population. Our findings were derived on a VDP threshold determined in never-smokers from a previous 3He MRI study
(9). The range of VDP for all subjects in our study was 2%–
18%, and the VDP data distribution was not normally distributed, but reflected a Poisson distribution. This may explain
why 42 of 60 subjects reported abnormal VDP. If a greater
threshold (vs. 95% CI) was implemented for abnormal VDP,
fewer ex-smokers would have been classified with abnormally
elevated VDP. For example, if the abnormal VDP threshold
was 5%, 33 of 60 ex-smokers would have been classified
with abnormally elevated VDP. Another inherent limitation
is that we did not acquire paired inspiratory–expiratory CT
scans which prevented us from using recently developed parametric response mapping (PRM) techniques (31) to quantify
air trapping in these subjects. Comparisons and spatial correlations between PRM measurements and 3He MRI ventilation and ADC measurements may have provided novel
information about the underlying structure–function relationships of preclinical or subclinical forms of COPD which
we could not uncover using measurements from inspiratory
CT alone. We must also acknowledge that 3He MRI may
9
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only be used at a limited number of research centers worldwide because of the limited supply of 3He gas and need for
specialized equipment and software. However, pulmonary
functional MRI using hyperpolarized 129Xe is emerging as
an attractive alternative with the potential for implementation
and translation. In this regard, longitudinal measurements in
these 60 ex-smokers will be undertaken using 129Xe and
more conventional 1H MRI methods. Finally, we also recognize that although this study evaluated 60 ex-smokers, a relatively large study by MRI standards, the sample size may have
limited our ability to detect significant relationships with CT
airway morphology and emphysema measurements and for
detecting significant differences in ADC after familywise error
correction. We also acknowledge that we focused only on exsmokers without airflow limitation; therefore, future work
investigating MRI ventilation measurements in currentsmokers would provide an understanding of acute effects of
cigarette smoke on pulmonary ventilation.
In conclusion, in ex-smokers without airflow limitation,
3
He MRI identified a subgroup with abnormal ventilation.
Although there were no other pulmonary function or CT differences in ex-smokers with normal or abnormal ventilation,
there were spatial relationships between ventilation defects
with both elevated ADC and abnormal subsegmental airway
morphology. These data suggest that a combination of very
mild airways disease and microstructural emphysematous
destruction are present in ex-smokers without airflow limitation warranting further longitudinal investigation.
ACKNOWLEDGMENTS
Funding source: The authors acknowledge funding from a
Canadian Institutes of Health Research (CIHR) Team Grant
for the Thoracic Imaging Network of Canada, CIHR Operating Grant MOP# 106437 and the Canadian Respiratory
Research Network (CRRN). Dr. Parraga also gratefully acknowledges salary support from a CIHR New Investigator
award.
The authors thank Sandra Blamires CCRC, for clinical coordination, Andrew Wheatley BSc, for production and
dispensing of 3He gas, and Trevor Szekeres RTMR, for
MRI of research volunteers.

SUPPLEMENTARY DATA
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.acra.2015.04.006.

REFERENCES
1. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England journal of
medicine 2004; 350(26):2645–2653.
2. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and
emphysema in chronic obstructive pulmonary disease. The New England
journal of medicine 2011; 365(17):1567–1575.

10

Academic Radiology, Vol -, No -, - 2015

3. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. American journal of respiratory and critical care medicine 2013; 187(4):347–365.
4. van Beek EJ, Dahmen AM, Stavngaard T, et al. Hyperpolarised 3He MRI
versus HRCT in COPD and normal volunteers: PHIL trial. The European
respiratory journal 2009; 34(6):1311–1321.
5. Kirby M, Mathew L, Heydarian M, et al. Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized (3)
He MR imaging. Radiology 2011; 261(1):283–292.
6. Fain SB, Gonzalez-Fernandez G, Peterson ET, et al. Evaluation of
structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. Academic radiology 2008; 15(6):753–762.
7. Svenningsen S, Kirby M, Starr D, et al. What are ventilation defects in
asthma? Thorax 2014; 69(1):63–71.
8. Mentore K, Froh DK, de Lange EE, et al. Hyperpolarized HHe 3 MRI of the lung
in cystic fibrosis: assessment at baseline and after bronchodilator and airway
clearance treatment1. Academic radiology 2005; 12(11):1423–1429.
9. Sheikh K, Paulin GA, Svenningsen S, et al. Pulmonary ventilation defects in
older never-smokers. J Appl Physiol (1985) 2014; 117(3):297–306.
10. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in
smokers compared to never-smokers. Journal of magnetic resonance imaging : JMRI 2005; 21(4):365–369.
11. Wang C, Mugler JP, 3rd, de Lange EE, et al. Lung injury induced by
secondhand smoke exposure detected with hyperpolarized helium-3
diffusion MR. Journal of magnetic resonance imaging : JMRI 2014;
39(1):77–84.
12. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in
asymptomatic smokers: detection with 3He MR imaging. Radiology
2006; 239(3):875–883.
13. Kirby M, Pike D, Coxson HO, et al. Hyperpolarized 3He ventilation defects
used to predict pulmonary exacerbations in mild to moderate chronic
obstructive pulmonary disease. Radiology 2014;140161.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry.
The European respiratory journal 2005; 26(2):319–338.
15. Kirby M, Heydarian M, Svenningsen S, et al. Hyperpolarized 3He magnetic
resonance functional imaging semiautomated segmentation. Academic
radiology 2012; 19(2):141–152.
16. Kirby M, Heydarian M, Wheatley A, et al. Evaluating bronchodilator effects
in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. Journal of applied physiology 2012; 112(4):651–657.
17. Niimi A, Matsumoto H, Amitani R, et al. Airway wall thickness in
asthma assessed by computed tomography: relation to clinical indices.
American journal of respiratory and critical care medicine 2000; 162(4):
1518–1523.
18. West JB. Respiratory physiology: the essentials. 8th ed. Lippincott Williams and Wilkins, 2008.
19. Wan ES, Hokanson JE, Murphy JR, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. American
journal of respiratory and critical care medicine 2011; 184(1):57–63.
20. Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression
of emphysema in COPD as determined by CT scanning and biomarker
expression: a prospective analysis from the ECLIPSE study. The lancet
Respiratory medicine 2013; 1(2):129–136.
21. Yablonskiy DA, Sukstanskii AL, Woods JC, et al. Quantification of lung
microstructure with hyperpolarized 3He diffusion MRI. Journal of applied
physiology 2009; 107(4):1258–1265.
22. Evans A, McCormack D, Ouriadov A, et al. Anatomical distribution of 3He
apparent diffusion coefficients in severe chronic obstructive pulmonary
disease. Journal of magnetic resonance imaging : JMRI 2007; 26(6):
1537–1547.
23. Miller RR, Muller NL, Vedal S, et al. Limitations of computed tomography in
the assessment of emphysema. The American review of respiratory disease 1989; 139(4):980–983.
24. Coxson HO, Leipsic J, Parraga G, et al. Using pulmonary imaging to move
chronic obstructive pulmonary disease beyond FEV1. American journal of
respiratory and critical care medicine 2014; 190(2):135–144.
25. Yahaba M, Kawata N, Iesato K, et al. The effects of emphysema on airway
disease: correlations between multi-detector CT and pulmonary function
tests in smokers. European journal of radiology 2014; 83(6):1022–1028.
26. Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements
of airway dimensions and emphysema in smokers. Correlation with lung

Academic Radiology, Vol -, No -, - 2015

function. American journal of respiratory and critical care medicine 2000;
162(3 Pt 1):1102–1108.
27. Coxson HO. Quantitative chest tomography in COPD research: chairman’s summary. Proceedings of the American Thoracic Society 2008;
5(9):874–877.
28. Coxson HO. Quantitative computed tomography assessment of airway
wall dimensions: current status and potential applications for phenotyping
chronic obstructive pulmonary disease. Proceedings of the American
Thoracic Society 2008; 5(9):940–945.

VENTILATION HETEROGENEITY IN EX-SMOKERS

29. Swift AJ, Wild JM, Fichele S, et al. Emphysematous changes and normal
variation in smokers and COPD patients using diffusion 3He MRI. European journal of radiology 2005; 54(3):352–358.
30. Fain SB, Altes TA, Panth SR, et al. Detection of age-dependent changes in
healthy adult lungs with diffusion-weighted 3He MRI. Academic radiology
2005; 12(11):1385–1393.
31. Galban CJ, Han MK, Boes JL, et al. Computed tomography-based
biomarker provides unique signature for diagnosis of COPD phenotypes
and disease progression. Nature medicine 2012; 18(11):1711–1715.

11

